Given that MSI and BRAFV600E mutation are molecular correlates specific for HME tumours, it can be postulated that ERBB4 promoter methylation is, rather, related to HME than specifically to the two other above-mentioned molecular correlates (Yagi et al. 2010). Here, ERBB4 is linked to neoplasm.